HealthcareServices

Global Prostate Specific Antigen (PSA) Test Market Forecast 2026–2035: Long-Term Growth Insights

March 2, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the prostate specific antigen (psa) test market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Prostate Specific Antigen (PSA) Test Market?

The prostate specific antigen (psa) test market has seen substantial expansion over recent years. This market is set to increase from $4.65 billion in 2025 to $5.19 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The historical growth of the market can be linked to the growing application of psa testing in clinical practice, the development of laboratory diagnostic services, increased public understanding regarding prostate cancer screening, the supply of immunoassay-based test kits, and the inclusion of psa testing in standard health examinations.

The market for prostate specific antigen (psa) tests is expected to demonstrate swift expansion over the coming years. This market is projected to grow to $8.17 billion in 2030, driven by a compound annual growth rate (CAGR) of 12.0%. This anticipated growth is attributed to advancements in high-precision psa assay technologies, the increasing adoption of decentralized diagnostic testing, the broadening of preventive cancer screening initiatives, greater investments in diagnostic automation, and a rising demand for cost-effective screening solutions. Significant trends for the forecast period include the increasing uptake of routine psa screening programs, a growing demand for point-of-care psa testing, the expanding use of high-sensitivity immunoassays, the extension of post-treatment monitoring applications, and an enhanced focus on early cancer detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp

Which Drivers Are Supporting The Rise Of The Prostate Specific Antigen (PSA) Test Market?

The rising prevalence of prostate cancer is anticipated to drive the expansion of the prostate-specific antigen (PSA) test market moving forward. Prostate cancer is a medical condition where malignant cells develop in the prostate gland, which is identified as a component of the male and female reproductive systems. The prostate-specific antigen (PSA) test is frequently utilized as a screening tool for prostate cancer in men, measuring the concentration of PSA in the bloodstream to assist in early identification and risk evaluation. For example, in March 2023, reports from the American Society of Clinical Oncology (ASCO), a US-based professional oncology organization, indicated that approximately 288,300 men in the US were diagnosed with prostate cancer, and around 34,700 people died in 2023. Consequently, the increase in prostate cancer cases is stimulating growth in the prostate-specific antigen (PSA) test market.

What Segments Are Identified Within The Structure Of The Prostate Specific Antigen (PSA) Test Market?

The prostate specific antigen (psa) test market covered in this report is segmented –

1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types

2) By Application: Screening, Post-Treatment Monitoring, Other Applications

3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

Subsegments:

1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests

2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits

3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA

4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)

Which Competitive Trends Are Impacting The Structure Of The Prostate Specific Antigen (PSA) Test Market?

Leading companies in the prostate-specific antigen (PSA) test market are concentrating on developing and introducing products, particularly home testing kits for prostate-specific antigen (PSA), to maintain their market presence. These home testing kits are self-administered diagnostic tools that empower individuals to collect samples, perform tests, and receive results without needing to visit a healthcare facility. For example, in September 2023, Randox, an Ireland-based health and toxicology company, launched an at-home testing kit for prostate-specific antigen (PSA). The PSA home test aims to measure PSA levels in the blood, indicating potential prostate abnormalities. PSA is a protein generated by prostate gland cells, and elevated levels can suggest various conditions, including an enlarged prostate, prostatitis, or a urinary tract infection, in addition to the possible existence of prostate cancer.

Which Major Industry Participants Are Leading The Prostate Specific Antigen (PSA) Test Market Growth?

Major companies operating in the prostate specific antigen (psa) test market are Siemens AG, F Hoffmann La Roche AG, Abbott Laboratories, Becton Dickinson And Company, PerkinElmer Inc, Beckman Coulter Inc, Bio Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, DiaSorin SpA, OPKO Health Inc, R And D Systems Inc, Meso Scale Diagnostics LLC, Tosoh America Inc, Fujirebio Europe NV, Boditech Med Inc, DRG International Inc, Enzo Life Sciences Inc, RayBiotech Inc, Novus Biologicals LLC, Creative Diagnostics Inc, Elabscience, LifeSpan BioSciences Inc, Accuquik Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Prostate Specific Antigen (PSA) Test Market?

North America was the largest region in the prostate specific antigen (PSA) test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (psa) test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Prostate Specific Antigen (PSA) Test Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp

Browse Through More Reports Similar to the Global Prostate Specific Antigen (PSA) Test Market 2026, By The Business Research Company

Endocrine Peptide Test Market Report 2026

https://www.thebusinessresearchcompany.com/report/endocrine-peptide-test-global-market-report

Prostate Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report

Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-nuclear-medicine-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795